Table 2.
Response | Clinical symptomatic response evaluation (No. of patients) | Biochemical response evaluation (No. of patients) | PERCIST (No. of patients) 68Ga-DOTATATE | RECIST 1.1 (No. of patients) |
---|---|---|---|---|
Complete response | 1 (4.5%) | 1 (4.5%) | 0 | 0 |
Partial response | 1 (4.5%) | 1 (4.5%) | 2 (9%) | 1 (4.5%) |
Stable disease | 13 (59.1%) | 15 (68.3%) | 12 (54.6%) | 13 (59.1%) |
Progressive disease | 7 (31.9%) | 5 (22.7%) | 8 (36.4%) | 8 (36.4%) |
PRRT, peptide receptor radionuclide therapy.